248 related articles for article (PubMed ID: 8650231)
1. Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.
Busslinger M; Klix N; Pfeffer P; Graninger PG; Kozmik Z
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6129-34. PubMed ID: 8650231
[TBL] [Abstract][Full Text] [Related]
2. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.
Morrison AM; Jäger U; Chott A; Schebesta M; Haas OA; Busslinger M
Blood; 1998 Nov; 92(10):3865-78. PubMed ID: 9808580
[TBL] [Abstract][Full Text] [Related]
3. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.
Iida S; Rao PH; Nallasivam P; Hibshoosh H; Butler M; Louie DC; Dyomin V; Ohno H; Chaganti RS; Dalla-Favera R
Blood; 1996 Dec; 88(11):4110-7. PubMed ID: 8943844
[TBL] [Abstract][Full Text] [Related]
4. Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
Hamada T; Yonetani N; Ueda C; Maesako Y; Akasaka H; Akasaka T; Ohno H; Kawakami K; Amakawa R; Okuma M
Br J Haematol; 1998 Aug; 102(3):691-700. PubMed ID: 9722295
[TBL] [Abstract][Full Text] [Related]
5. t(9;14)(p13;q32) involving the PAX-5 gene: a unique subtype of 14q32 translocation in B cell non-Hodgkin's lymphoma.
Amakawa R; Ohno H; Fukuhara S
Int J Hematol; 1999 Feb; 69(2):65-9. PubMed ID: 10071452
[TBL] [Abstract][Full Text] [Related]
6. A case of primary splenic large cell lymphoma with a t(9;14)(p13;q32).
Kawakami K; Amakawa R; Miyanishi S; Okumura A; Hayashi T; Kurata M; Ohno H; Ohno Y; Fukuhara S
Int J Hematol; 1998 Feb; 67(2):191-8. PubMed ID: 9631587
[TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma carrying t(9;14)(p13;q32)/PAX5-immunoglobulin heavy chain gene is characterized by nuclear positivity of MUM1 and PAX5 by immunohistochemistry.
Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Maekawa F; Takeoka K; Hayashida M; Sakamoto S; Akasaka T; Honjo G
Hematol Oncol; 2020 Apr; 38(2):171-180. PubMed ID: 31955451
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
Souabni A; Jochum W; Busslinger M
Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).
Iida S; Rao PH; Ueda R; Chaganti RS; Dalla-Favera R
Leuk Lymphoma; 1999 Jun; 34(1-2):25-33. PubMed ID: 10350329
[TBL] [Abstract][Full Text] [Related]
10. Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation.
Morrison AM; Nutt SL; Thévenin C; Rolink A; Busslinger M
Semin Immunol; 1998 Apr; 10(2):133-42. PubMed ID: 9618759
[TBL] [Abstract][Full Text] [Related]
11. The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
Ohno H; Ueda C; Akasaka T
Leuk Lymphoma; 2000 Feb; 36(5-6):435-45. PubMed ID: 10784387
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.
Ohno H; Furukawa T; Fukuhara S; Zong SQ; Kamesaki H; Shows TB; Le Beau MM; McKeithan TW; Kawakami T; Honjo T
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):628-32. PubMed ID: 2153959
[TBL] [Abstract][Full Text] [Related]
13. In vitro Epstein-Barr virus-immortalized lymphoma cell line carrying t(9;14)(p13;q32) chromosome abnormality, derived from splenic lymphoma with villous lymphocytes.
Daibata M; Taguchi T; Nemoto Y; Iwasaki S; Ohtsuki Y; Taguchi H
Int J Cancer; 2006 Jan; 118(2):513-7. PubMed ID: 16049984
[TBL] [Abstract][Full Text] [Related]
14. t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma.
Ohno H; Takeoka K; Kishimori C; Nakagawa M; Fukutsuka K; Maekawa F; Hayashida M; Akasaka T; Sumiyoshi S
J Clin Exp Hematop; 2021 Dec; 61(4):216-220. PubMed ID: 34707037
[TBL] [Abstract][Full Text] [Related]
15. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas.
Baron BW; Nucifora G; McCabe N; Espinosa R; Le Beau MM; McKeithan TW
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5262-6. PubMed ID: 8506375
[TBL] [Abstract][Full Text] [Related]
16. Regulation of PAX-6 gene transcription: alternate promoter usage in human brain.
Okladnova O; Syagailo YV; Mössner R; Riederer P; Lesch KP
Brain Res Mol Brain Res; 1998 Oct; 60(2):177-92. PubMed ID: 9757029
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.
Ye BH; Chaganti S; Chang CC; Niu H; Corradini P; Chaganti RS; Dalla-Favera R
EMBO J; 1995 Dec; 14(24):6209-17. PubMed ID: 8557040
[TBL] [Abstract][Full Text] [Related]
18. Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR.
Sonoki T; Willis TG; Oscier DG; Karran EL; Siebert R; Dyer MJ
Leukemia; 2004 Dec; 18(12):2026-31. PubMed ID: 15496980
[TBL] [Abstract][Full Text] [Related]
19. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
20. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
